Glytec, LLC

Glytec is a healthcare technology company specializing in intelligent glycemic management software for hospital systems. Founded in 2006, Glytec developed the first FDA-cleared software for glucose management and has since deployed its platform across 400+ hospitals. The flagship offering, GlytecOne, is a unified clinical decision support platform that combines FDA-cleared Glucommander® insulin dosing algorithms with workflow automation, real-time clinical decision support, enterprise analytics, and population health intelligence. The platform integrates seamlessly with electronic health records (EHRs) to deliver personalized, real-time insulin dosing recommendations, standardized clinical workflows, and comprehensive performance analytics aligned with CMS eCQM reporting requirements. Glytec's solutions have demonstrated significant outcomes: 99.8% reduction in inpatient hypoglycemia, 3.1% A1C reduction, 68% reduction in 30-day readmissions, and 6–8x ROI. The platform addresses mandatory CMS glycemic harm eCQM reporting beginning in 2026, helping hospitals strengthen patient safety, optimize clinical workflows, and reduce medication-related adverse events.